RKLB Bounces Hard, but the Neutron Overhang Remains

Rocket Lab closed Tuesday at $58.31, up 14.6% on the week, a sharp reversal from the 21% slide that defined the prior note. The recovery puts the stock back above $50 but still leaves it down 21% over the past month, and well below the analyst consensus target of $102.15.

The rebound outpaced close peers by a meaningful margin. FLY gained 22% on the week and LUNR added 9.7%, so space and launch-adjacent names broadly recovered. RDW, SATL and VOYG each added between 7% and 14%. The sector-wide lift complicates any attempt to read the RKLB move as a company-specific re-rating. Retail attention is running well above its own 90-day norm, with ORTEX's Wikipedia-and-page-view signal posting a z-score of 2.3 as of October 21, the highest in the tracked window. That kind of attention spike often accompanies volatile price moves in either direction rather than a change in fundamental view.

Short positioning has eased modestly but remains material. Short interest is at 8.8% of free float, down about 3.2% on the week from a mid-October peak near 9.5%, reflecting some covering as the stock rebounded. Borrow conditions are loose: availability stands at 229%, meaning roughly two shares are available to lend for every one already borrowed, and the cost to borrow is a low 0.43%. That combination tells you there is no squeeze pressure here. Covering looks opportunistic rather than forced. Options sentiment is close to neutral, with the put/call ratio at 0.76, barely above its 20-day average of 0.75 and a z-score of just 0.14. No defensive positioning is building ahead of the November 9 earnings report, at least not yet.

The Street remains unanimously positive on direction but is still working through the numbers. Every active rating is at Buy or equivalent. The target cuts documented in last week's note, Citizens from $130 to $90, Keybanc from $135 to $100, have not reversed. Barclays and Citigroup both initiated in early October with Overweight and Buy ratings at $85 and $105 respectively, adding fresh voices without changing the consensus shape. The mean target of $102.15 implies the stock would need to almost double from current levels to reach where analysts collectively have it modelled. That gap is not closing quickly. The bull case rests on the $2.36 billion backlog, a 100% mission success rate across 21 Electron launches in FY25 and 18 year-to-date, and the longer-term potential of Neutron's projected $50 million to $55 million per-launch pricing once operational. The bear case is more immediate: Neutron's first launch has slipped from Q4 2026 into 2027 after carbon-composite manufacturing defects, pushing first heavy-lift revenue further out and cutting FY27 revenue estimates to $1,186.3 million from $1,299.3 million. The valuation multiples still look extreme on trailing figures, with EV/EBITDA above 580x, reflecting a market still pricing in the growth story rather than the current earnings base.

One structural factor worth noting: the pending acquisition of Iridium Communications means RKLB's share count is expected to increase. ORTEX puts the probability of a Russell 1000 and Russell 3000 share-count adjustment at 84%, and an MSCI World adjustment at 65%, with estimated announcement dates around mid-to-late June 2027. These are forecasts, not confirmed changes, and the dates are estimated. The mechanics of index tracker demand tied to a larger share count are real but distant. The flow number for the MSCI World event is put at $122 million of buying, 0.1 days of average volume, so not a market-moving force on its own.

On the activist register, VK Services, the vehicle associated with founder Peter Beck, has filed three amendments to its 13D, most recently in February 2026 at 6.5% of shares. Beck himself filed in March 2026 at 7.51% of the class, down from 10.02% previously. These are as-last-disclosed positions and either party could have moved further since. BlackRock added 2.6 million shares in the most recent quarter to reach 6.8% of the company. T. Rowe Price increased its position by 3.3 million shares. The CFO, Adam Spice, sold roughly $9.9 million of stock on October 1 under a 10b5-1 plan, a pre-arranged schedule rather than a discretionary move, so it carries limited informational weight.

Earnings arrive November 9. The last print, in August, produced a 3.4% one-day drop. The one before that, in May, saw the stock gain 10.7% on the day. Whether the November report shifts the narrative around Neutron's revised timeline is the question the positioning data, so far, offers no strong answer to.